TY - JOUR
T1 - Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands
AU - Wu, Zhijun
AU - Hruby, Victor J.
N1 - Publisher Copyright:
Copyright © 2019 American Chemical Society.
PY - 2019/10/22
Y1 - 2019/10/22
N2 - Opioid ligands are a large group of G-protein-coupled receptor ligands possessing high structural diversity, along with complicated structure-activity relationships (SARs). To better understand their structural correlations as well as the related SARs, we developed the innovative template-based alignment modeling in our recent studies on a variety of opioid ligands. As previously reported, this approach showed promise but also with limitations, which was mainly attributed to the small size of morphine as a template. With this study, we set out to construct an artificial μ-agonist template to overcome this limitation. The newly constructed template contained a largely extended scaffold, along with a few special μ-features relevant to the μ-selectivity of opioid ligands. As demonstrated in this paper, the new template showed significantly improved efficacy in facilitating the alignment modeling of a wide variety of opioid ligands. This report comprises of two main parts. Part 1 discusses the general construction process and the structural features as well as a few typical examples of the template applications and Part 2 focuses on the template refinement and validation.
AB - Opioid ligands are a large group of G-protein-coupled receptor ligands possessing high structural diversity, along with complicated structure-activity relationships (SARs). To better understand their structural correlations as well as the related SARs, we developed the innovative template-based alignment modeling in our recent studies on a variety of opioid ligands. As previously reported, this approach showed promise but also with limitations, which was mainly attributed to the small size of morphine as a template. With this study, we set out to construct an artificial μ-agonist template to overcome this limitation. The newly constructed template contained a largely extended scaffold, along with a few special μ-features relevant to the μ-selectivity of opioid ligands. As demonstrated in this paper, the new template showed significantly improved efficacy in facilitating the alignment modeling of a wide variety of opioid ligands. This report comprises of two main parts. Part 1 discusses the general construction process and the structural features as well as a few typical examples of the template applications and Part 2 focuses on the template refinement and validation.
UR - http://www.scopus.com/inward/record.url?scp=85073169864&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073169864&partnerID=8YFLogxK
U2 - 10.1021/acsomega.9b02244
DO - 10.1021/acsomega.9b02244
M3 - Article
AN - SCOPUS:85073169864
SN - 2470-1343
VL - 4
SP - 17457
EP - 17476
JO - ACS Omega
JF - ACS Omega
IS - 17
ER -